Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NVP-2203 by NVP Healthcare for Hypercholesterolemia: Likelihood of Approval
NVP-2203 is under clinical development by NVP Healthcare and currently in Phase III for Hypercholesterolemia. According to GlobalData, Phase III...